440 results about "Eye disease" patented technology

Provided in the present invention are a TSHR antagonist compound, a pharmaceutical composition, and a preparation method therefor and the use thereof. The compound has good TSHR antagonism, and is used in the treatment of thyroid-associated conditions and / or diseases, such as hyperthyroidism, Graves' disease, Graves' ophthalmopathy, and thyroid eye disease, and in the preparation of a drug for treating such conditions or diseases.

Provided in the present invention are a TSHR antagonist compound, a pharmaceutical composition, a preparation method therefor and the use thereof. The compound (I) has a good TSHR antagonistic effect, and is used for treating thyroid-associated disorders and / or diseases, such as hyperthyroidism, Graves' disease, Graves' ophthalmopathy, and thyroid eye disease, and for preparing drugs for such disorders or diseases.

The present disclosure provides a compound of formula H having excellent PDE4B inhibitory activity, and a pharmaceutical composition thereof and a use thereof. The compound provided by the present disclosure can be used for effectively treating PDE4-related diseases and disorders, including but not limited to inflammatory respiratory diseases, inflammatory bowel diseases, inflammatory joint diseases, inflammatory skin diseases, inflammatory eye diseases, and diseases or cancers of the peripheral or central nervous system.

The invention discloses a multi-task learning-based retinal vessel segmentation and analysis method and system, and relates to the technical field of medical image processing, and the method comprises the steps: introducing an EMCAD module into an R-Unet model, and carrying out the retinal vessel segmentation; designing an area percentage quantization function; a multi-task learning framework RetiVas-MTNet is constructed and is used for auxiliary diagnosis of eye diseases. The EMCAD module fuses a channel attention CAB mechanism and a space attention SAB mechanism: 1) generating a channel weight through adaptive maximum pooling and average pooling, and strengthening key channel features; (2) context connection of local features is established through large kernel convolution, and the space attention weight is calculated; according to the invention, the EMCAD module is introduced, so that the segmentation precision of the microvessels is improved; the blood vessel area percentage is quantitatively designed, so that the crossing from qualitative segmentation to quantitative diagnosis is realized; a multi-task learning framework RetiVas-MTNet provides a comprehensive solution for automatic diagnosis of eye diseases.

The invention discloses a visual conversion system, method and equipment for eye disease auxiliary diagnosis and a storage medium, and solves the problems of single function, high data dependence, large computing resource demand and weak interpretability in the field of eye disease auxiliary diagnosis in the prior art. The system comprises an input processing module, a visual transformer trunk, a hybrid expert layer, a decoder head and an output generation module. According to the visual conversion system for eye disease auxiliary diagnosis, various ophthalmology imaging modes can be processed, multiple tasks can be executed, and the input processing module, the visual transformer trunk, the mixed expert layer, the decoder head and the output generation module in the system cooperate to reduce calculation requirements and maintain accuracy at the same time; the expert is dynamically selected according to the complexity of the input image, it is ensured that different inputs can obtain optimal feature processing, accuracy and efficiency are both considered, a decoder structure can be customized according to the features of different tasks, and the output precision of each task is ensured.

Antibodies and compositions against Insulin-Like Growth Factor-1 Receptor (IGF-1R) and uses thereof for treating thyroid eye disease (TED) are provided herein. Anti-IGF-1R antibodies and compositions described herein can be used in methods of treating or reducing the severity of thyroid eye disease (TED) in subjects in need thereof, by inhibiting the activity of IGF-1R with such antibodies and compositions.

The invention relates to a compound according to general formula (I), which acts as a bradykinin (BK) B2 receptor antagonist; to a pharmaceutical composition containing one or more of the compound(s) of the invention; to a combination preparation containing at least one compound of the invention and at least one further active pharmaceutical ingredient; and to said compound(s) for use as in a method of treating a skin disorder; eye disease; ear disease; mouth, throat and respiratory disease; gastrointestinal disease; liver, gallbladder and pancreatic disease; urinary tract and kidney disease; disease of male genitale organs and female genitale organs; disease of the hormone system; metabolic disease; cardiovascular disease; blood disease; lymphatic disease; disorder of the central nervous system; brain disorder; musculoskeletal system disease; allergy disorder; pain; infectious disease; inflammatory disorder; injury; immunology disorder; cancer; hereditary disease; or edema.

The invention belongs to the technical field of nano-drugs, and discloses a multifunctional nano-drug delivery system for treating neovascular eye diseases and a preparation method of the multifunctional nano-drug delivery system. The nano drug delivery system disclosed by the invention is a composite nano preparation which takes dendritic mesoporous silica nanoparticles as a carrier and co-loads cerium zirconium oxide nano enzyme and an anti-VEGF (vascular endothelial growth factor) drug, various active oxygen can be efficiently removed, oxygen is continuously released through catalytic decomposition of hydrogen peroxide, a retina hypoxia microenvironment is improved, and the retina hypoxia effect is improved. According to the present invention, the anti-VEGF drug delivery system can reduce the oxidative stress induced retinal pigment epithelial cell apoptosis rate, reduce the inflammatory reaction, and simultaneously achieve the slow release and the controlled release of the anti-VEGF drug, and the drug effect maintenance time can achieve more than 60 days, such that the multi-target synergistic treatment can be achieved through the synergistic regulation of the multiple pathological links such as oxygen deficit-oxidative stress-inflammation-angiogenesis, and the anti-VEGF drug delivery effect can be achieved. The choroidal neovascularization can be effectively inhibited by single intravitreal injection, and a new strategy of multi-target collaborative treatment is provided for neovascular macular degeneration and other eye diseases.

The invention relates to a construction method of a thyroid-related eye disease animal model, and belongs to the technical field of biology. The invention provides a thyroid-associated ophthalmopathy animal model construction method, which comprises: (1) separating and purifying in vitro peripheral blood collected from a thyroid-associated ophthalmopathy patient to obtain an exosome; and (2) injecting the exosome into a to-be-modeled animal to prepare the thyroid-associated ophthalmopathy animal model. According to the invention, exosomes are extracted from in-vitro peripheral blood of patients with thyroid-associated ophthalmopathy and are injected into animals, so that the thyroid-associated ophthalmopathy animal model with a plurality of pathological characteristics such as orbital tissue inflammatory response, fibrosis, orbital lesion, thyroid dysfunction and the like is successfully constructed; the method can be widely applied to pathological mechanism research of thyroid-related eye diseases and screening and evaluation of thyroid-related eye disease treatment drugs.

The invention discloses an ophthalmology AI intelligent ward control system and method based on voice interaction. The system comprises an anti-noise voice acquisition unit, a multi-modal identity verification unit, a specialized semantic analysis unit, a medical rule engine unit, a safety protection unit, a multi-modal feedback unit and a dynamic optimization unit. Medical equipment noise is filtered out through a microphone array and an adaptive beam forming technology, and an instruction is analyzed in combination with a dialect recognition engine; executing triple identity verification, and performing forced superposition authentication on the cognitive impairment patient; calling an ophthalmology knowledge base to identify the risk keyword and generate a structured instruction; dynamically regulating and controlling the environment according to the eye disease type, and intercepting violation settlement according to a medical insurance rule; precise equipment voice control is forbidden, and when an emergency keyword is triggered, an OCT image is pushed preferentially and is directly connected with a physician; a big-character highlight interface and tactile pulse feedback are provided for the visually impaired patient, and data are synchronized to the HIS system in real time; and the dynamic optimization unit continuously updates the knowledge base and the medical insurance model. According to the invention, the instruction identification precision, the medical safety and the service suitability of the ophthalmology ward are obviously improved.

The present invention relates to methods for treating or reducing the severity of thyroid eye disease. In particular, the present invention provides methods for treating or reducing the severity of thyroid eye disease in patients in need thereof comprising administering an IGF-1R antagonist antibody according to specific dosage regimens. Pharmaceutical compositions comprising the IGF-1R antagonist antibody for use in the methods are also described.

The invention provides a thyroid-related eye disease intraorbital soft tissue volume measurement method and system, and is applied to the technical field of data processing. Three-dimensional medical image data and system abnormal state information are obtained, the three-dimensional medical image data comprise CT images and MRI images, and the system abnormal state information comprises artifacts, isolated noisy points and irregular boundaries; data preprocessing is carried out on the three-dimensional medical image data, standardized image data is generated, and the standardized image data is formed by carrying out ternary processing on spatial registration, noise suppression and gray level normalization; processing the standardized image data and the system abnormal state information to generate an initial segmentation mask; processing the initial segmentation mask to generate an optimized mask; processing the optimized mask and the three-dimensional medical image data to generate soft tissue volume data; and processing the soft tissue volume data, the system abnormal state information and the historical volume data to generate a volume dynamic change report.

Transcorneal and fiberoptic laser delivery systems and methods for the treatment of eye diseases wherein energy is delivered by wavelengths transparent to the cornea to effect target tissues in the eye for the control of intraocular pressure in diseases such as glaucoma by delivery systems both external to and within ocular tissues. External delivery may be affected under gonioscopic control. Internal delivery may be controlled endoscopically or fiberoptically, both systems utilizing femtosecond laser energy to excise ocular tissue. The femtosecond light energy is delivered to the target tissues to be treated to effect precisely controlled photodisruption to enable portals for the outflow of aqueous fluid in the case of glaucoma in a manner which minimizes target tissue healing responses, inflammation and scarring.

The invention relates to the technical field of medical instruments, in particular to a cornea protection eyeshade for a patient with hyperthyroidism eye disease, which comprises an eyeshade main body, the eyeshade main body comprises a support frame, a protection cover and a fitting layer are mounted on two sides of the support frame, and a self-adaptive fitting adjusting assembly, a multifunctional linkage module and a magnetic suction buffer assembly are further mounted on the support frame. The self-adaptive fitting adjusting assembly is used for driving the fitting layer to adapt to eye contours of different patients, the multifunctional linkage module is used for achieving switching of eye moisturizing and one-way light transmission of the patients, the magnetic attraction buffering assembly is used for relieving compression during wearing and fixing, and the monitoring assembly is installed on the fitting layer and used for monitoring state information of the eye contours of the patients. The monitoring assembly is in signal connection with a controller, and the controller is used for manually adjusting the moisturizing amount and the light transmission mode of the multifunctional linkage module according to the state information. According to the method, full-scene and personalized cornea protection is provided for a patient with hyperthyroidism synophthalmia, and the cornea is prevented from being damaged by exposure, dryness, strong light or compression.

The invention discloses a thyroid-related eye disease auxiliary verification method based on SPECT / CT and federal learning. The thyroid-related eye disease auxiliary verification method comprises the steps that A, image data standardization and orbit area extraction are carried out; b, extracting a preliminary segmentation mask of each rectus in the CT image; c, fusing the structure prior mask, and obtaining an extraocular muscle fine segmentation mask through multi-mode collaborative segmentation; d, utilizing extraocular muscle fine segmentation masks, SPECT and CT images, fusing segmentation prior and multi-modal features to perform deep discrimination, performing automatic prediction of thyroid-related eye disease activity staging, and outputting a prediction probability; and E, based on a dynamic model combination strategy of style similarity and uncertainty quantization, obtaining a dynamic combination model of segmentation and classification adapted to new domain feature distribution, and predicting TAO activity. According to the method, accurate segmentation of extraocular muscle structures and accurate prediction of TAO activity in an invisible data center can be realized, auxiliary verification data support is provided for diagnosis of thyroid-related eye diseases, and the diagnosis accuracy is improved.

The present invention relates to a D-galactopyranose compound of formula (1)whereinthe pyranose ring is α-D-galactopyranose, and these compounds are high affinity galectin-1 and / or galectin 3 inhibitors for use in treatment of inflammation; fibrosis; scarring; keloid formation; aberrant scar formation; surgical adhesions; septic shock; cancer; metastasising cancers; autoimmune diseases, metabolic disorders; heart disease; heart failure; pathological angiogenesis; eye diseases; atherosclerosis; metabolic diseases; diabetes type I; diabetes type II; insulin resistance; Diastolic heart failure; asthma; liver disorders.

The invention provides an image-based eye lesion grading analysis method and device, a medium, a program product and a terminal, and the method comprises the steps: obtaining one or more eye lesion images, inputting the one or more eye lesion images to a pre-trained first model, and generating a corresponding eye feature vector; for a single image, calculating the similarity between the feature vector and each eye disease category, and outputting a prediction category with the highest similarity; and for a plurality of images, respectively calculating the similarity between the feature vectors and each category, and realizing adaptive weighted integration by using the second model to obtain a final prediction category. Sub-model subdivision and risk level layering are carried out according to prediction categories, and a structured risk layering report is output. The problem that in the prior art, the diagnostic value of multi-image information in complex cases is difficult to effectively evaluate is solved, the accuracy of ultrasound in serious vitreous lesion and intraocular tumor recognition is remarkably improved through a self-adaptive weighted integration mechanism, high-risk patient screening and clinical decision making are supported, and the application scene of ultrasound in ophthalmic diagnosis is expanded.

Described herein are devices used to treat high intraocular pressure and glaucoma. An example device includes a plate comprising a first surface opposite a second surface. The first surface includes a series of fluid channels. The device also includes a first coating on the first surface and a second coating on the second surface. The device is configured to lower intraocular pressure by draining aqueous humor from an anterior chamber to subconjunctival space of a patient's eye.

The invention provides a method of treating or reducing the severity of thyroid-associated ophthalmopathy (TAO), also known as thyroid eye disease (TED) or Graves' ophthalmopathy or orbitopathy (GO), or a symptom or aspect thereof, in subjects that have undergone prior treatment for TAO, TED, or GO, and either did not respond to said prior treatment or relapsed after said prior treatment. The invention also provides antibodies, or antigen binding fragments thereof, and pharmaceutical compositions useful in the disclosed methods.

The invention provides a three-dimensional medical image segmentation method and system for thyroid-related eye diseases, and is applied to the technical field of data processing. Multi-modal medical image data, a coarse-grained segmentation result and a fine-grained segmentation result are obtained, the multi-modal medical image data comprise a CT image and an MRI image, the multi-modal medical image data are preprocessed, a fused image body is generated, and the fused image body is formed by registration and feature fusion of the CT image and the MRI image; processing the fused image body and the coarse-grained segmentation result to generate a fine segmentation result; processing the fine segmentation result to generate a preliminary segmentation mask; processing the preliminary segmentation mask and the multi-modal medical image data to generate a mixed loss function; and processing the preliminary segmentation mask, the mixed loss function and the extraocular muscle attachment point position based on a dynamic post-processing strategy to generate a final segmentation result.

Provided herein are methods of treating or reducing the severity of thyroid eye disease (TED), also known as thyroid-associated ophthalmopathy (TAO), or Graves' ophthalmopathy or orbitopathy (GO), as well as antibodies, or antigen binding fragments thereof, and pharmaceutical compositions comprising them, useful in the methods.

The invention discloses a continuous optical zoom slit-lamp microscope system and an inspection method and application thereof, and belongs to the technical field of ophthalmology medical equipment. The system is composed of a continuous zooming module, a light source module, a data processing module, a 3D imaging module and an AI identification module. The inspection method comprises the steps of equipment initialization and head position fixation of an inspected person, AI low-magnification (5 *) preliminary screening, adaptive lens high-magnification (40 *) fine observation, dynamic light source adjustment, three-dimensional data acquisition and cloud intelligent diagnosis. The method is applied to examination and intelligent diagnosis of eye diseases such as cataract. The problems that a traditional slit-lamp microscope is discontinuous in zooming, inconvenient to operate, lack of intelligent diagnosis and free of 3D stereoscopic display are solved, and the objective of the invention is to realize simple and convenient equipment operation, continuous examination process, intelligent diagnosis and stereoscopic display, facilitate collective teaching, significantly improve the diagnosis efficiency and accuracy of eye diseases such as cataract and the like, and improve the diagnosis efficiency and accuracy of eye diseases such as cataract and the like. And DICOM standard data cloud sharing and remote consultation are supported.

The invention discloses a thyroid eye disease activity evaluation method and system based on an eye image, and aims to solve the problems that the existing clinical activity score cannot reflect continuous change of an illness state and is susceptible to subjective influence. The method comprises the following steps: acquiring original image data containing an eye region; performing standardized preprocessing on the image data; extracting multi-scale inflammatory features and structural features from the preprocessed image; carrying out cross-modal fusion on the extracted multi-scale features; calculating an activity quantitative score based on the fused comprehensive features; and outputting a visual report of the quantitative score and the evaluation conclusion. The system comprises an image acquisition module, an image preprocessing module, a feature extraction module, a feature fusion module, an activity evaluation module and a result output module. According to the technical scheme, objective quantitative evaluation of thyroid eye disease activity can be achieved, the consistency and repeatability of evaluation results are improved, remote image acquisition and automatic analysis are supported, and the space-time limitation of traditional clinical evaluation is broken through.

The present application relates to an ophthalmic preparation and use thereof. Specifically, the present application relates to an ophthalmic preparation of pilocarpine and use thereof for treating eye diseases. The ophthalmic preparation of pilocarpine provided by the present application has the beneficial effects of good stability and less eye irritation.

The invention discloses a magnesium alloy composite material and a preparation method and application thereof, and belongs to the technical field of magnesium alloy materials. The magnesium alloy composite material comprises a polymer and a magnesium alloy material, and the mass percentage of the magnesium alloy material in the magnesium alloy composite material does not exceed 50%. The composite material can be obtained by blending a polymer and a magnesium alloy material. The magnesium alloy composite material can be used for preparing devices or medicines for treating eye diseases, and is particularly used for preparing glaucoma drainage implantation instruments. Before magnesium alloy is degraded, the glaucoma drainage implantation instrument containing the magnesium alloy composite material is small in flow capacity, and low intraocular pressure can be prevented; after the magnesium alloy is degraded, a porous structure can be formed, so that the flow capacity of the drainage implantation instrument is increased, a normal drainage effect is achieved, and in addition, the magnesium alloy can also play a role in slowly releasing magnesium ions.

The invention relates to the technical field of biological medicine, in particular to a medicine for improving thyroid-related eye diseases and application of the medicine. The single-chain antibody provided by the invention has small molecular weight and good physiological activity, and can effectively inhibit the activity and function of IGF1R mediated by IGF1, thereby inhibiting cell proliferation. According to the medicine prepared from the recombinant adeno-associated virus, the treatment cost can be remarkably reduced, side effects caused by repeated injection of antibody medicines are avoided, the safety is very high, and a new clinical treatment method and strategy are provided for inhibiting pathological phenotypes of thyroid-associated ophthalmopathy.

An implant device for an eye disease to be inserted into an eyeball may include: a tube having one end to be inserted into an anterior chamber of the eyeball, the tube comprising a hollow portion through which aqueous humor is drained; and a ripcord inserted into the hollow portion of the tube to control an amount of aqueous humor drainage through the tube. In the implant device, an inner diameter of the tube and a diameter of the ripcord are determined so that pressure formed in the anterior chamber of the eyeball when the tube is inserted into the anterior chamber of the eyeball is within a preset pressure range. The pressure formed in an anterior chamber to an optimal range through an appropriate combination of the tube and the ripcord inserted into the tube.

The invention discloses an ophthalmic disease curative effect evaluation method and device, terminal equipment and a storage medium, and the method comprises the steps: determining a first visual feature set of a patient under disease deterioration and a second visual feature set of the patient under disease improvement according to the disease type and disease degree of the patient; processing the original image according to the first visual feature set and the second visual feature set to generate a plurality of candidate subjective images after improvement and deterioration for a patient to select, and comparing a target subjective image which is selected by the patient and conforms to the vision of the patient with an initial subjective image generated during the first doctor seeing; therefore, the eye disease treatment effect report of the patient can be finally determined, so that the patient can be helped to evaluate the eye disease treatment effect through the remote mobile terminal under the condition that the patient cannot see a doctor offline, and the patient can be effectively helped to know the treatment condition of the eye disease of the patient in time.

The invention discloses an eye health risk assessment system, which comprises a multi-modal data acquisition module, a structured knowledge base module, a dynamic questionnaire engine, a large model reasoning module and a hierarchical intervention module through multi-module cooperation, and is characterized in that the multi-modal data acquisition module integrates multiple interfaces; obtaining user chief complaint, eye and whole body health data, and constructing a multi-dimensional portrait; a structured knowledge base constructs an eye disease knowledge graph through a standardized coding system, association between symptoms and risk levels is established through clustering analysis, and dynamic evaluation is supported; and the dynamic questionnaire engine performs intelligent layered inquiry according to the chief complaint, so that the data acquisition quality is improved. And the large model reasoning module analyzes the data and links a knowledge base, and accurately outputs a disease list and a risk level. And the hierarchical intervention module triggers a response strategy of a corresponding level according to the risk level. All the modules form a closed loop from data acquisition, analysis and evaluation to hierarchical intervention, and the convenience, accuracy and effectiveness of eye health management are remarkably improved.